Harvard and 10x to face anti-competitive claims over genomics patents

13-07-2023

Liz Hockley

Harvard and 10x to face anti-competitive claims over genomics patents

Jon Bilous / Shutterstock.com

Delaware court permits counterclaims from Vizgen and Nanostring in separate suits | Firms say patents-in-suit were covered by ‘open and non-exclusive licenses’.


Harvard, 10x Genomics, Vizgen, Nanostring, single-cell spatial transcriptomics, anti-competitive practice, monopoly, patents, Merscope, breach of contract

LSIPR